National Heart, Lung, and Blood Institute (NHLBI): Pulmonary Fibrosis trials

The registry lists 12 Pulmonary Fibrosis studies with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 3No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Role of Genetic Factors in the Development of Lung DiseaseRecruitingNCT00001532
• Low-Dose Danazol for the Treatment of Telomere Related DiseasesCompletedNCT03312400Phase 2
• Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary FibrosisCompletedNCT02315586
• Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung DiseaseCompletedNCT02055222
• Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System DiseasesCompletedNCT00366509
• Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary HypertensionCompletedNCT00352482Phase 2
• Linkage Study in Familial Pulmonary FibrosisCompletedNCT00016627
• Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung DiseasesCompletedNCT00005317
• Identification of Genes Associated With Lung Disease in Patients With Rheumatoid ArthritisCompletedNCT00001885
• Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid ArthritisCompletedNCT00001884
• Segmental Bronchoalveolar LavageCompletedNCT00001618
• Diffuse Fibrotic Lung DiseaseCompletedNCT00000596Phase 2